InvestorsHub Logo
Followers 70
Posts 2498
Boards Moderated 0
Alias Born 08/11/2017

Re: ApollyonZ post# 49908

Wednesday, 02/09/2022 1:32:08 PM

Wednesday, February 09, 2022 1:32:08 PM

Post# of 50866
$MSSV...Revenue increased by 1,243.99%..



..Warrants granted in the year ended December 31, 2020 were valued using the Black Scholes Model..expected volatility ranging of 411.72%
..Series BB Preferred Stock.. calculated at a price of $1.20..
..Global Stem Cells Group’s operations cover every aspect of the regenerative medicine industry.
..$11,600,000.. have a three (3) year maturity date
..Revenue from viable cell therapy and immune support related products along with physician training was $153,583 from August 19, 2021 to September 30, 2021. The key reason for the increase in revenue was a result of the acquisition of Global Stem Cells Group.
..Other expense decreased by $6,460,049 for the three months ended September 30, 2021

https://www.sec.gov/ix?doc=/Archives/edgar/data/1760026/000121390021066881/f10q0921_mesonumis.htm

Little over a month, $153K from cell-Immune therapy and training during all while Covid disruption.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MSSV News